Clincosm LogoSign in Get a demo

Diabetes

Showing NaN - NaN of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +208 more
Oct 2, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Little Rock, Arkansas
  • +80 more
Jun 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • basal insulin
  • Birmingham, Alabama
  • +57 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes Trial in United States (Medtronic MiniMed 530G Insulin Pump)

Completed
Has Results
  • Diabetes
  • Medtronic MiniMed 530G Insulin Pump
  • Little Rock, Arkansas
  • +42 more
Feb 11, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +98 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 1
  • inhaled human insulin
  • +2 more
  • Birmingham, Alabama
  • +95 more
Sep 3, 2018

Type 2 Diabetes, Diabetes Trial in Miami, San Antonio, Renton (REMD-477)

Completed
  • Type 2 Diabetes Mellitus
  • Diabetes
  • REMD-477
  • Miami, Florida
  • +2 more
Apr 9, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin degludec, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • +2 more
  • Greenbrae, California
  • +50 more
Mar 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Tuscumbia, Alabama
  • +116 more
Mar 1, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Impaired Glucose Tolerance (IGT), Diabetes Trial in San Antonio (Exenatide, Placebo)

Completed
Has Results
  • Impaired Glucose Tolerance (IGT)
  • Diabetes
  • San Antonio, Texas
    Texas Diabetes Institute and UTHSCSA
Oct 19, 2017